Plutux
What 4 Institutions Published on Oracle (ORCL) in the Past 3 Months: Targets, Ratings, and the OCI/AI Backlog-Capex/Margin Tradeoff cover
Institutional ViewsORCL•7 min read

What 4 Institutions Published on Oracle (ORCL) in the Past 3 Months: Targets, Ratings, and the OCI/AI Backlog-Capex/Margin Tradeoff

Across the past six months, public institutional calls on Oracle cluster mostly in the Buy/Outperform camp, with price targets spanning roughly the high-$100s to the mid-$200s. The clearest disagreements are about how much incremental OCI/AI demand is likely to convert into sustainable margins versus near-term capex and balance-sheet strain. Evidence is strongest where filings or major wire/outlet pages explicitly state the rating and target on a specific date.

Published Aug 26, 2026Updated Aug 26, 2026

Oracle · May 18 – Aug 6, 2026

Most tracked institutions are bullish on Oracle and are marking up price targets, implying the market needs less concern about capex/margin pressure than their bullish OCI/AI backlog assumptions suggest.

Institutions

4

Target range

$190 – $330

Median $240

Stance

Bullish 4
How to read the evidence grades
  • AInstitution's own document — Published by the institution itself — research page, disclosure, transcript, or an on-the-record analyst appearance.
  • BWire service citing the report — Reuters, Bloomberg, CNBC and similar, directly attributing the research note.
  • CMultiple independent reports — Several independent secondary reports agreeing on the same rating or target.
  • DRatings aggregator only — A ratings aggregator only. Treat the number as reported, not as confirmed.

Price targets over time

Every target published in this window, by date. The line under a dot is that firm's previous target.

  1. UBSBuy

    $285$245

  2. CitigroupBuy

    $320$330

  3. RBC CapitalOutperform

    $160$190

  4. OppenheimerOutperform

    $210$235

UBSOracle

Karl KeirsteadLowered price target

Buy → BuyD
Price target$285$245

UBS kept a Buy stance while trimming its Oracle target, suggesting it still expects AI/cloud demand to support fundamentals despite margin/capex volatility.

Why

  • Target reduction reflects a less optimistic valuation setup versus the prior $285.
  • Despite the cut, UBS maintained a Buy rating.

Evidence (1)

CitigroupOracle

Raised price target

BuyB
Price target$320$330

Citi increased its Oracle target into the AI/OCI buildout narrative, keeping a Buy stance centered on long-term infrastructure momentum.

Why

  • Citi raised the price recommendation/target to $330 from $320.
  • Citi reiterated a Buy stance in the same update.

Evidence (1)

RBC CapitalOracle

Rishi JaluriaRaised price target

Outperform → OutperformB
Price target$160$190

RBC Capital raised its Oracle target as part of its positive view, while framing the change through peer-multiple/strategy confidence rather than a downgrade to the demand outlook.

Why

  • RBC Capital raised its price target to $190 from $160.
  • RBC Capital maintained an Outperform/Sector Perform-style bullish stance in the same update.

Evidence (1)

OppenheimerOracle

Raised price target

OutperformB
Price target$210$235

Oppenheimer increased its Oracle target, pointing to AI infrastructure demand as a key driver behind improving expectations.

Why

  • Oppenheimer raised its target to $235 from $210 while keeping an Outperform rating.
  • The disclosed driver is strong technology infrastructure spending/AI demand.

Evidence (1)

Capex vs margin: how OCI/AI backlog is being valued

The street’s OCI/AI backlog bet: bullish targets, but with capex/margin sensitivity showing up as target cuts

The sourced calls above are unanimously bullish (no bearish/hold examples were found with verifiable rating+target inside the window using readable public snippets/pages). Within that bullish consensus, UBS illustrates the main internal debate: it trimmed its target from the prior $285 to $245 while still keeping a Buy, consistent with investors questioning how quickly AI/OCI backlog turns into free cash flow and margins versus absorbing higher infrastructure spending.

  • Most institutions are willing to pay up for delivery on the OCI/AI backlog (Buy/Outperform-style ratings across the evidence set).
  • Target dispersion is mainly valuation and near-term cost sensitivity (e.g., UBS’s cut versus its earlier raise).
  • Where capex/margin risk dominates, institutions tend to cut targets rather than exit the bull case (as seen in UBS keeping Buy after lowering the target).
This archive reflects only views that had publicly readable, quoteable rating/target facts inside the window. It does not cover every analyst note; it documents what major institutions were publicly willing to state about ORCL’s AI/OCI economics during this period.

Closest high-level “capital-spend / AI infrastructure delivery” comps in the public record

NNVIDIA CorporationNVDA--
--Vol --
-
Mixed
  • AI infrastructure demand assumptions flow through to semis and networking.
  • Any shift in hyperscaler capex affects both compute demand and AI platform spend.
AAmazon.com, Inc.AMZN--
--Vol --
-
Bullish
  • Cloud backlog/capex conversion is a key comparator for Oracle’s OCI/AI translation.
  • Operating leverage tends to be judged against infrastructure build pace.
MMicrosoft CorporationMSFT--
--Vol --
-
Bullish
  • Azure AI execution is often used as a benchmark for hyperscaler margin delivery.
  • Capex-to-margin trajectory can anchor relative valuation debates.
About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026